Joint Honours Degree in Journalism and Media and Communications.
Junior Journalist at Orange Fox Media, creating content for vaping publications, media partnerships, and blogs. Journalist at The Cannavist, securing the UK's first commercial cannabis publication deal with WHSmiths and Easons in Ireland. Published numerous articles covering different aspects of the cannabis industry and interviewed experts. Collaborated on official media partnerships, including the Europe CBD Expo official show guide.
Vapouround, Evade Magazine, StudyInn.
Lucy is a respected journalist and content writer within the medical cannabis sector. Passionate about removing the stigma that surrounds cannabis-based treatments, and improving patient outcomes, Lucy is dedicated to creating high quality content that educates, informs, and raises awareness of medical cannabis in the UK. During her time at Releaf Lucy has spearheaded our 2023 market research report, Say No To Pain, which, as the UK’s largest study of attitudes towards medical cannabis, provided invaluable insight into the current medical cannabis climate in the UK. She has also been a large contributor to our blog and education section, and as well as producing medical cannabis patient travel guides, Lucy has helped to create one of the largest medical cannabis glossaries available online. Lucy started her content career in the vaping industry as a junior journalist and quickly segued into cannabis journalism in 2019. Lucy has previously written for The Cannavist, the UK’s first cannabis-based publication sold in high-street retailers such as W H Smiths and Easons in Ireland, has collaborated on official media partnerships including the Europe CBD Expo show guide, and has conducted in-depth interviews industry members, healthcare professionals, and patients alike.
As well as being World Dementia Day, this Wednesday is the International Day of Education. Held every year on the 24th of January, International Day of Education was implemented by the United Nations back in December 2018, just one month after the UK legalised medical cannabis.
When December comes to a close, a lot of us adopt a ‘new year, new me’ philosophy and are eager to set targets and new year resolutions to become the best version of ourselves. While we set our sights high, sometimes despite our best interest, the cold, dark and busy winters can feel draining, and finding the motivation to keep up momentum can be a challenge.
If you’re new to the world of medical cannabis, the wide range of content and information that centres around cannabinoids, and their concentrations within your medicine, can make it feel like you’re trying to decipher another language.
In the heart of UK healthcare policy, Victoria Atkins' appointment as Health Secretary stirs controversy due to her explicit recusal from cannabis-related decisions, spotlighting the intricate dance of politics, personal interest, and the quest for equitable medical cannabis access.
In the chill of winter, our immune system requires some extra TLC to stay strong. While vaccines offer targeted protection against individual viruses, other holistic practices and easy measures can fortify our bodies natural defences, and equip them with extra armour.
The spirit of giving and generosity is amplified at Christmas, and often people choose to ask their loved ones or friends to donate to a charitable cause on their behalf as opposed to buying them a gift.
Considering the increasing prevalence of medical cannabis use and cannabis-based treatments, it is unsurprising that many patients are now starting to wonder whether their use of this medication could influence life insurance policies.
The Cannabis Industry Council (CIC) has released guidance for medical cannabis patients to ensure that they act safely, and are treated appropriately, when behind the wheel. Distributed for free in physical leaflet format to attendees at The Patient Conference, which took place earlier this month during Medical Cannabis Awareness Week, this document states the rules and regulations that relate to medical cannabis patients and driving.
The question ‘what does cannabis smell like?’ is a complex one to answer. Generally speaking, cannabis has a distinctive earthy, herbal aroma that often includes notes of citrus, pine or spice, mainly due to its unique terpene profile.
During Medical Cannabis Awareness Week, the annual Patient Conference took place on the 3rd of November at Conway Hall. We were proud to not only be in attendance, but one of the official sponsors of the event.
Earlier this month, Self Care Week was celebrated all over the UK - but we think its importance rings true all year round. That’s why we’ve launched our latest blog series: Wellness Wednesday; to take a look at alternative, natural and holistic approaches to improving our wellbeing.
It has been announced that the official cannabis flos (flower) monograph will be published in supplement 11.5 of the European Pharmacopoeia in January 2024. This will establish international quality and standards testing and identification processes for cannabis flowers, and its derived products, used in medicinal practices.
On the five-year anniversary of medical cannabis legalisation in the UK, during Medical Cannabis Awareness Week, The Cannabis Industry Council launched a patient survey to further understand patients' experiences with medical cannabis.
Daydreaming of exploring Asia’s incredible landscapes, culture, and vibrant cities is a common occurrence for many, and nations like the Philippines and Singapore feature on bucket lists around the world as a ‘must-see destination’. But, Asia is also extremely well known for enacting strict punishments to suspected drug smugglers and traffickers.
Dreaming of idyllic white sand beaches and secluded spots in Polynesia, or experiencing extreme outback adventures in Australasia is a desire shared by many, and places like Hawaii, New Zealand, and Australia feature on many people’s bucket lists. Yet, for medical cannabis patients, planning their dream holiday may be filled with dread - due to the confusing and often conflicting cannabis regulations in different countries.
The 1st of November 2023 is an important day for many in the medical cannabis community, because it marks five years of its legalisation in the UK. But, what you may not have known is that November the 1st is also the day dedicated to raising awareness of stress – a condition medical cannabis has shown potential in alleviating.
In this article, we will analyse some key insights and statistics relating to patient access and experiences with medical cannabis, as well as discussing changes in public perceptions and awareness, and medical cannabis research that has taken place since 2018. We’ll also explore the economic impact of medical cannabis by analysing the facts and figures available, and recap regulatory changes that have taken place, whilst shedding light on the challenges that may be coming in the future.
Two weeks ago, Chris Philp MP revealed he is in support of the proposals made by NHS England and the Advisory Council for the Misuse of Drugs (ACMD), that would allow for the electronic prescription of schedule 2 and schedule 3 drugs.
To get a deeper understanding of the medical cannabis industry in the UK, we’ve decided to investigate some of the key statistics that shape the cannabis landscape as we know it. The Releaf Medical Cannabis Statistic Series examined the impact of medical cannabis across three crucial domains: the economy, health, and society.
October is known as the month of falling leaves, cosy jumpers, and the start of spooky season – but, what you may not have known is that October is also World Menopause Awareness Month, with Menopause Awareness Day taking place on the 18th.
Depression is a debilitating condition that affects about 280 million people around the world. Subjecting patients to what has been described as an overwhelming emotional numbness, extreme sadness or all-consuming hopelessness, depression is a mental health condition that can affect a person’s emotional, physical and social wellbeing. In this article, we aim to explain the evidence available surrounding the application of medical cannabis in depression symptom management, including its short-term effects and potential benefits, as well as the risks associated with taking medical cannabis.
CBD is a non-intoxicating cannabinoid derived from the cannabis sativa L. genus, often sourced from hemp cultivars (which are part of the same plant species) thanks to their high CBD and low THC content. It has gained significant attention in recent years for its potential wellness benefits, particularly in the treatment of anxiety, pain, and inflammation. It is also commonly taken as a complementary therapeutic option for the reduction of depression symptoms, alongside traditional treatment protocols.
The rise of CBD in recent years has sparked a wave of curiosity and enthusiasm for its therapeutic potential, and possible health benefits. However, as with any wellness trend, it’s important to separate the fact from the fiction. Because each of our bodies are unique, the way our appetites work, and the way CBD interacts with and affects our bodies, depend on the individual and this can vary significantly from person to person.
With the social and political acceptance and awareness of medical cannabis growing here in the UK, the need for both patients and the wider public to have a better understanding of how cannabis (and its contained active ingredients) interacts with the body is more pressing than ever before. Deep within our bodies, there is a remarkably intricate regulatory system called the endocannabinoid system (ECS) that is still somewhat overlooked in the wider medical field, despite its crucial role in our wellbeing. This complex network is made up of receptors, enzymes, and naturally produced cannabinoids called endocannabinoids.
"Since starting my treatment plan with Releaf, I’m genuinely shocked at how well it has worked."Chloe Durrington, Releaf patient
